Literature DB >> 4301611

The use of rivanol treatment for removal from sera of nonspecific inhibitors of enterovirus and reovirus hemagglutination.

B Styk, N J Schmidt, J Dennis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4301611     DOI： 10.1093/oxfordjournals.aje.a120900

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  5 in total

1.  Hemoagglutination and hemagglutination inhibition tests with enterovirus type 70.

Authors:  R Kono; E Tajiri; K Miyamura; A Sasagawa; T Tsuruhara
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

2.  Complement-dependent cell lysis assay for quantitation of rubella antibodies.

Authors:  Y Fujimiya; T Suto
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

3.  Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation.

Authors:  J C Hierholzer; M T Suggs; E C Hall
Journal:  Appl Microbiol       Date:  1969-11

4.  Removal of nonspecific hemagglutination inhibitors, immunoglobulin G, and immunoglobulin A with streptococcal cells and its application to the rubella hemagglutination inhibition test.

Authors:  K Kawano; Y Minamishima
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

Review 5.  Virus-erythrocyte interactions.

Authors:  C Howe; L T Lee
Journal:  Adv Virus Res       Date:  1972       Impact factor: 9.937
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.